Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2010
08/17/2010US7777041 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents
08/17/2010US7777036 1'-(2-Trifluoromethylbenzoyl)-1',2',3',6'-tetrahydro-[2,4']bipyridinyl-5-carboxylic acid (2-cyclopropylethyl)amide; for diseases mediated by stearoyl-CoA desaturase enzymes, preferably SCD1, especially those related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7776889 also known as protease activated receptor-1 (PAR-1) antagonists or as cannabinoid (CB2) receptor antagonists, used for treating thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, congestive heart failure and cancer
08/17/2010US7776885 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
08/17/2010US7776884 Cyclic derivatives as modulators of chemokine receptors activity
08/17/2010US7776876 administering cyclic Glycyl-2-Allyl Proline as as neuroprotectants, for the prophylaxis of nervous system disorders
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
08/17/2010US7776791 N-heterocyclyl phenyl-substituted cyclic ketoenols
08/17/2010CA2545092C Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
08/17/2010CA2461963C Cyclic amine compounds
08/17/2010CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/17/2010CA2397734C Water soluble prodrugs of azole compounds
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/17/2010CA2370412C Pharmaceutical compounds
08/12/2010WO2010091411A1 Piperidinyl cyclic amido antiviral agents
08/12/2010WO2010091386A2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010WO2010091382A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010WO2010091126A1 Xanthene dyes comprising a sulfonamide group
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010090347A1 Dihydroquinolinone derivatives
08/12/2010WO2010090200A1 Phenylimidazole compounds
08/12/2010WO2010090077A1 Organic electroluminescent element, and illumination device and display device each comprising the element
08/12/2010WO2010090009A1 Indoline derivatives
08/12/2010WO2010089353A1 Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
08/12/2010WO2010089211A1 Novel herbicides
08/12/2010WO2010089210A1 Novel herbicides
08/12/2010WO2010042489A3 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/12/2010WO2010036640A3 Compounds for the treatment of inflammatory disorders
08/12/2010US20100204480 Method for producing 4-aminobut-2-enolides
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/12/2010US20100204471 Mapk/erk kinase inhibitors
08/12/2010US20100204470 method for salt preparation
08/12/2010US20100204296 Novel Polymorphs of Darifenacin Free Base and its Hydrobromide Salt
08/12/2010US20100204274 Piperidinyl derivatives as modulators of chemokine receptor activity
08/12/2010US20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
08/12/2010US20100204242 Piperazine Derivative Having Affinity for the Histamine H3 Receptor
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204233 Imidazole derivatives
08/12/2010US20100204220 Heterocyclic modulators of cannabinoid receptors
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204207 Compounds and Methods for Treating Dyslipidemia
08/12/2010US20100202033 3h-naphth0 [2,1-b] pyrans as photochromic dichroic dyes and optical article containing them
08/12/2010CA2751987A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010CA2751536A1 Indoline derivatives
08/12/2010CA2751458A1 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010CA2751441A1 Novel herbicides
08/12/2010CA2751440A1 Novel herbicides
08/12/2010CA2750714A1 Dihydroquinolinone derivatives
08/12/2010CA2750704A1 Phenylimidazole compounds
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2215079A1 Inhibitors of c-fms kinase
08/11/2010EP2215074A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
08/11/2010EP2215067A1 Amino-heteroaryl-containing prokineticin 1 receptor antagonists
08/11/2010EP2214667A2 Small molecule inhibitors of parp activity
08/11/2010EP2099763B1 2-aminoquinolines as 5-ht(5a) receptor antagonists
08/11/2010EP1636209B1 Epoxy compound and cured epoxy resin product
08/11/2010EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3
08/11/2010EP1263731B1 Method for producing 5-aryl nicotinaldehydes
08/11/2010EP1150676B1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
08/11/2010CN1827600B Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it
08/11/2010CN101801934A 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/11/2010CN101801932A Substituted nicotinamide compounds and the use thereof in pharmaceutical products
08/11/2010CN101801930A 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
08/11/2010CN101801925A antiviral compounds
08/11/2010CN101801382A Stereoselective process for preparing purine dioxolane nucleoside derivatives
08/11/2010CN101798298A Imidazole derivatives
08/11/2010CN101798282A Multi-substituted fluorine-containing pyridine
08/10/2010US7772407 (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
08/10/2010US7772405 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
08/10/2010US7772392 prostaglandin receptor agonists; for treating various ocular hypertensive conditions such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
08/10/2010US7772270 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
08/10/2010US7772256 2-[6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol; for imaging amyloid deposits in living patients
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772238 such as N-hydroxy-6-{1-[(4-methoxybenzyl)amino]-2-[(4-methoxyphenyl)amino]-2-oxoethyl}-1-benzothiophene-2-carboxamide, used to treat cancer, tumors, neurodegenerative, autoimmune, allergic and inflammatory diseases, and as histone deacetylase inhibitors
08/10/2010US7772237 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
08/10/2010US7772233 Arylamino N-heteroaryl compounds as MEK inhibitors
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2462132C 1,2,4-triazole compounds
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2249542C Pyrazole derivatives, their preparation and their use in pharmaceuticals
08/05/2010WO2010088455A2 Cromolyn derivatives and related methods of imaging and treatment
08/05/2010WO2010087727A1 Enaminocarbonyl compounds and their use
08/05/2010WO2010087454A1 Quinoline derivative
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010087315A1 Anti-alzheimer’s disease agent
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087306A1 Anti-neurodegenerative disease agent
08/05/2010WO2010086403A1 Azetidines as histamine h3 receptor antagonists
08/05/2010WO2010086366A1 4-aryl-butane-1,3-diamides
08/05/2010WO2010086311A1 Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives
08/05/2010WO2010086251A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010WO2010023512A8 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
08/05/2010US20100197939 Process for the enantioselective preparation of pregabalin
08/05/2010US20100197926 Method for producing indole derivative having piperidine ring
08/05/2010US20100197925 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
08/05/2010US20100197919 Method for producing macrolide compound and production intermediate thereof
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 694